NEURELIS
Neurelis is a specialty pharmaceutical company, licenses, develops, and commercializes product candidates for epilepsy and the broader central nervous system (CNS) market. It provides a differentiated approach to target unmet medical needs. Their application of novel technologies is designed to enhance the therapeutic benefit and patient care. The company was incorporated in 2007 and is based in Encinitas, California.
NEURELIS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2007-01-01
Address:
Encinitas, California, United States
Country:
United States
Website Url:
http://www.neurelis.com
Total Employee:
101+
Status:
Active
Contact:
858-251-2100
Total Funding:
206.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Google Universal Analytics Apache Euro IPv6 Google Maps
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Board_member
Board_member
2021-08-01
Current Employees Featured
David Hale Executive Chairman/Co-Founder @ Neurelis
Executive Chairman/Co-Founder
Craig Chambliss Co-founder, CEO & President @ Neurelis
Co-founder, CEO & President
2007-10-01
Cam Garner Director @ Neurelis
Director
David V. Smith Member, Board of Directors @ Neurelis
Member, Board of Directors
2021-08-01
Brittany Bradrick Chief Financial Officer @ Neurelis
Chief Financial Officer
2021-10-01
Edward Maggio Consultant @ Neurelis
Consultant
2018-11-01
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2018-12-03 | Aegis Therapeutics | Aegis Therapeutics acquired by Neurelis | N/A |
Investors List
Philos & Partners
Philos & Partners investment in Series D - Neurelis
LYZZ Capital
LYZZ Capital investment in Series D - Neurelis
Decheng Capital
Decheng Capital investment in Series D - Neurelis
Cormorant Asset Management
Cormorant Asset Management investment in Series D - Neurelis
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series D - Neurelis
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Neurelis
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Neurelis
LYZZ Capital
LYZZ Capital investment in Series B - Neurelis
LYZZ Capital
LYZZ Capital investment in Series A - Neurelis
Key Employee Changes
Date | New article |
---|---|
2021-10-18 | Neurelis Announces Addition of Brittany Bradrick as CFO and Expansion of Leadership Team and Board of Directors |
Official Site Inspections
http://www.neurelis.com Semrush global rank: 1.08 M Semrush visits lastest month: 30.74 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Neurelis.com lookup results from whois.networksolutions.com server:
- Domain created: 15th-Jun-2007
- Domain updated: 29th-Jun-2023
- Domain expires: 15th-Jun-2025 0 Years, 71 Days left
- Website age: 17 Years, 294 Days
- Registrar Domain ID: 1030841930_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: domain.operations@web.com
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- CASS.NS.CLOUDFLARE.COM
- GREG.NS.CLOUDFLARE.COM